3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Cytarabine
34
Cyclophosphamide
21
Vincristine
20
Methotrexate
18
Dexamethasone
18
Mercaptopurine
16
Idarubicin
16
nilotinib
15
Daunorubicin
15
Imatinib Mesylate
13
fludarabine
12
Granulocyte Colony-Stimulating Factor
12
Asparaginase
12
Rituximab
11
Doxorubicin
10
Prednisolone
9
Etoposide
8
Prednisone
7
Thioguanine
6
Teniposide
6
Mitoxantrone
6
Dasatinib
6
venetoclax
5
fludarabine phosphate
5
Vindesine
5
Stem Cell Transplantation
5
Ifosfamide
5
Azacitidine
4
posaconazole
3
pirtobrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pneumococcal Vaccines
×
Other hematologic neoplasm
×
Clear all
NCT00919321
2014-02-19
KLL2
Tampere University Hospital
Phase 4
Completed
32 enrolled